Abstract We present the case of a de novo vertebral artery dissecting aneurysm (VADA) after endovascular trapping of a ruptured VADA on the contralateral side. The first ruptured VADA involved the posterior inferior cerebellar artery, which was successfully treated by endovascular internal trapping using a stent. A follow-up study at 3 months revealed a de novo VADA on the contralateral side. The second VADA was successfully embolized using coils while normal arterial flow in the vertebral artery was preserved using a stent. Increased hemodynamic stress may cause the development of a de novo VADA on the contralateral side.
Introduction
Vertebral artery (VA) dissecting aneurysms (VADA) with a hemorrhagic presentation have a high rate of rebleeding and mortality [10] . Immediate treatment is necessary to avoid lethal rebleeding. Endovascular internal trapping is currently the first choice for treating ruptured VADAs [13, 14] . However, VADA treatment involving the origin of the posterior inferior cerebellar artery (PICA) is still controversial because it is difficult to preserve the PICA via internal trapping. A new endovascular technique using a stent was developed to overcome this problem [6, 9, 15] . Another problem related to internal trapping is hemodynamic changes in the cerebral circulation, which may cause another dissection on the contralateral side. We present the case of a patient with a de novo VADA after endovascular trapping of a ruptured PICA-involved VADA on the contralateral VA.
Case report
A 55-year-old woman presented with a disturbance of consciousness. She complained of sudden occipitalgia on the left side 1 week before the examination. She had no family history or past history, including connective tissue disorders. Computed tomography (CT) revealed a subarachnoid hemorrhage (Fig. 1a) . Three-dimensional CT angiography demonstrated a dilatation and narrowing of the left VA, indicating a VADA (Fig. 1b) . The patient was diagnosed as having World Federation of Neurosurgical Societies grade IV subarachnoid hemorrhage caused by a ruptured left VADA. She was sedated and intubated, and emergency cerebral digital subtraction angiography was performed. Vertebral angiography showed a left VADA that included the PICA origin (Fig. 2) . The diameter of both VAs was similar (right 3.5 mm, left 3.3 mm). The diameter of the left PICA was 1.4 mm and it perfused a wide area of the cerebellum. We decided to treat the patient using endovascular internal trapping while preserving the PICA. Triple antiplatelet therapy, comprising 300 mg aspirin, 300 mg clopidogrel, and 100 mg cilostazol, was administered, and platelet function was confirmed using the Verify Now platelet function assay (Accumetrics, San Diego, CA).
Under general anesthesia, a Headway17 microcatheter (MicroVention, Tustin, CA, USA) was threaded into the left PICA from the right VA via the VA union and the left VA in a retrograde fashion to place the stent. Another microcatheter (Excelsior SL-10; Boston Scientific, Fremont, CA, USA) was placed in the aneurysmal dilatation in the left VA for internal trapping. A 2.5 × 17 mm LVIS Jr. stent (MicroVention, Tustin, CA, USA) was inserted via the left PICA to the left distal VA, just proximal to the origin of the anterior spinal artery. The withdrawn Headway17 microcatheter was introduced into the aneurysm for double-catheter coil embolization (Fig. 3a) . The VADA was then completely occluded using 13 detachable coils (Fig. 3b) . Angiography at 1 week showed an occluded VADA with preserved left PICA flow. The patient recovered well with no neurological deficits and she was discharged home 1 month later. She was prescribed triple antiplatelet therapy for 1 month and her blood pressure remained normal.
Angiography 3 months after initial treatment revealed complete occlusion of the left VADA with patent PICA flow, but also showed a de novo VADA on the right side (Fig. 4a) . The intention was to occlude this de novo VADA and preserve the patency of the right VA. Under general anesthesia, a microcatheter (Headway17) was placed just proximal to the VA union for stenting, and another microcatheter (Headway17) was placed into the aneurysmal dilatation for coil embolization. A 3.5 × 28 mm LVIS Jr. stent was placed in the right VA covering the dissecting segment. Four detachable coils were then placed into the aneurysmal dilatation from the microcatheter in place. Complete occlusion of the aneurysm while preserving the right VA flow was achieved without any complications (Fig. 4b, c) . The patient showed an 
Discussion
A ruptured VADA should be treated as soon as possible because these lesions show an extremely high rate of rebleeding [10] . When treating a VADA, the angioarchitecture including VA dominancy, location of the PICA origin, anterior spinal artery involvement, and bilateral lesions should be considered. Recent developments in endovascular treatment include a new therapeutic strategy called stent-assisted coil embolization, which can preserve normal VA flow using a stent. However, stent placement in the acute stage of subarachnoid hemorrhage may cause ischemic complications [6, 9] . If the VADA is Fig. 3 a Maximum intensity projection image shows good deployment of the LVIS Jr. stent between the left distal VA and the left PICA (arrow). Two microcatheters for coil placement are also seen in the aneurysm (arrowheads). b Threedimensional reconstructed image after internal trapping of the left VADA shows good patency of the stented PICA and occlusion of the left VA unilateral and the affected side can be sacrificed, surgical or internal trapping of the affected VA is believed to be the best treatment in the acute stage of subarachnoid hemorrhage [10, 13, 14] .
Because the PICA is one of the major arteries supplying the cerebellar hemisphere, involvement of the PICA is an important factor in the treatment of VADA. Mizutani et al. classified VADAs into four types according to their location in relation to the PICA origin [10] : pre-PICA, post-PICA, non-PICA and PICA-involved types. Pre-PICA, post-PICA, and non-PICA types can be treated by internal trapping of the affected VA while preserving the PICA. Treatment of the PICA-involved type requires PICA reconstruction. Conventional treatment of the PICA-involved type involves endovascular segmental occlusion using coils followed by PICA-to-PICA anastomosis or occipital artery-to-PICA bypass. Stent-assisted coil embolization is currently a helpful and alternative way to treat the PICA-involved type of VADA [13, 14] .
Some authors have reported the efficacy and safety of VA-PICA stenting for the PICA-involved type of VADA [2, 6, 15] . There are several methods of stent deployment, and the direction of stenting depends on the position of the PICA origin in relation to the aneurysm site and angulation. In the present patient, the PICA was located at the distal part of the aneurysmal dilatation and it originated at an acute angle from the left VA. The contralateral approach seemed to be straighter for stenting. Stenting into the PICA is sometimes challenging because of its small caliber, and stent patency is a major concern when the stent is placed in small vessels. The LVIS Jr. microstent has several advantages over the currently available intracranial stents [11] . The smallest delivery system facilitates navigation and precise advancement in small vessels. Although the LVIS Jr. is intended for use in aneurysms located on arteries of diameter 2-3.5 mm, some have used it in vessels of diameter less than 2 mm without occlusion of the stent [1, 11] and with a high degree of safety and a high rate of aneurysm occlusion. The LVIS Jr. stent appears to be effective and suitable for the treatment of VADA in the posterior circulation. In addition, adequate antiplatelet therapy is needed to prevent ischemic complications. In the present patient, triple antiplatelet therapy was started and platelet function was monitored using the Verify Now assay.
Although our treatment strategy for the left VADA seemed to be reasonable, a de novo VADA developed on the contralateral side. There are only a few reports of de novo VADA after occlusion of the contralateral VA [3-5, 8, 12] . Previously reported cases are summarized in Table 1 . The interval between the initial dissection and the detection of de novo contralateral dissection varies from patient to patient. Most patients were treated using conservative therapy. For an asymptomatic de novo VADA, conservative therapy may provide a good outcome. However, once the patient develops symptoms (subarachnoid hemorrhage or infarction), the clinical course is life-threatening and surgical treatment is difficult because of an inability to trap the remaining VA. In the present patient, a de novo VADA developed even with good blood pressure control. Because conservative treatment was not an appropriate choice, we decided to perform endovascular treatment for the right VADA even though it was asymptomatic. The mechanism of development of these aneurysms is not clear. The present patient had no risk factors for arterial dissection such as hypertension, diabetes mellitus or connective tissue disorder. Occlusion of the affected VA may cause increased blood flow in the contralateral VA, resulting in increased hemodynamic stress, which has been shown in several studies. Yasui et al. reported that the diameter of the VA increases after occlusion of the contralateral VA [16] . Kono et al. performed computational fluid dynamic simulations of contralateral VA trapping. In their simulated case of bilateral VADAs, trapping increased the wall sheer stress in the dome surface of the contralateral aneurysm [7] . Excessive hemodynamic stress can lead to disruption of the internal elastic lamina and consequently result in artery dissection. Aggressive volume loading in the acute phase of subarachnoid hemorrhage for the treatment of vasospasm also contributes to artery dissections [3] .
Conclusion
Increased hemodynamic stress may lead to the development of a dissecting aneurysm. After internal trapping for the treatment of a VADA, radiological follow-up is necessary to detect de novo dissection caused by posttherapeutic hemodynamic changes.
